Skip Navigation LinksHome > September 18, 2014 - Volume 39 - Issue 9 > Preexposure prophylaxis: An emerging clinical approach to pr...
Nurse Practitioner:
doi: 10.1097/01.NPR.0000452976.92052.fa
Feature: HIV

Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults

Blackwell, Christopher W. PhD, ARNP, ANP-BC, CNE, AGACNP-BC

Collapse Box

Abstract

The HIV antiretroviral drug emtricitabine/tenofovir disoproxil fumarate (Truvada) was recently approved as preexposure prophylaxis (PrEP) therapy for adults at high risk for sexually acquired HIV infection. This article reviews the data supporting the efficacy of PrEP, and provides other relevant data regarding the implementation of PrEP.

Lippincott Williams & Wilkins.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.